Evidence map›Paper›PMID 42569210›Full record

ArticleACS organic & inorganic Au2026

Pursuing the Red-Shift in GlycoporphyrinsA New Synthetic Approach toward Glycoconjugates from the

Jakub Mitrzak, Maciej Malinowski

Abstract read
In one paragraph

Article in ACS organic & inorganic Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jakub MitrzakWarsaw University of Technology, Faculty of Chemistry, ul. Noakowskiego 3, Warsaw 00-664, Poland.
Maciej MalinowskiWarsaw University of Technology, Faculty of Chemistry, ul. Noakowskiego 3, Warsaw 00-664, Poland.ORCID https://orcid.org/0000-0002-4586-8482

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photodynamic therapy is a promising approach to anticancer treatment. For further development of this technique, new photosensitizers that better meet biological criteria are highly desired. Glycoporphyrins are considered more than favorable synthetic targets in this matter. This is due to their increased solubility in aqueous solutions and their targeting ability toward cancer cells. Herein, we report synthetic studies, and we propose an original Sonogashira-based strategy toward unique porphyrin-glycal conjugates. The proposed methodology allowed us to synthesize 5 new examples of photosensitizers in which the sugar unit influenced another crucial factorthe bathochromic shift of the photosensitizer's absorption profile. These structures were able to absorb wavelengths from the region of 740-780 nm. The studies present the development of a synthetic strategy toward water-soluble glycoporphyrins and the initial recognition of their singlet oxygen production ability.

Indexed as

glycalsglycoporphyrinpalladium catalysisphotosensitizer(s); ROSporphyrin conjugatesonogashira reaction

Identifiers

PMID42569210
PMCPMC13449439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.